Citadel Advisors’s Embecta EMBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$179K Buy
20,200
+9,000
+80% +$93.8K ﹤0.01% 11523
2025
Q4
$133K Sell
11,200
-19,100
-63% -$252K ﹤0.01% 11421
2025
Q3
$428K Sell
30,300
-4,800
-14% -$60.7K ﹤0.01% 9512
2025
Q2
$340K Buy
35,100
+15,100
+76% +$170K ﹤0.01% 9516
2025
Q1
$255K Buy
20,000
+10,000
+100% +$160K ﹤0.01% 9946
2024
Q4
$207K Buy
10,000
+4,400
+79% +$72.1K ﹤0.01% 10403
2024
Q3
$79K Sell
5,600
-18,000
-76% -$262K ﹤0.01% 11431
2024
Q2
$295K Buy
23,600
+3,300
+16% +$40.1K ﹤0.01% 9174
2024
Q1
$269K Sell
20,300
-21,060
-51% -$326K ﹤0.01% 9703
2023
Q4
$783K Buy
41,360
+2,600
+7% +$42.7K ﹤0.01% 7179
2023
Q3
$583K Buy
38,760
+10,300
+36% +$193K ﹤0.01% 7725
2023
Q2
$615K Sell
28,460
-8,760
-24% -$239K ﹤0.01% 7482
2023
Q1
$1.05M Sell
37,220
-3,420
-8% -$97K ﹤0.01% 6684
2022
Q4
$1.03M Buy
40,640
+22,500
+124% +$687K ﹤0.01% 6766
2022
Q3
$522K Sell
18,140
-2,860
-14% -$84.7K ﹤0.01% 8367
2022
Q2
$532K Buy
+21,000
New +$605K ﹤0.01% 8504

Other funds holding EMBC

Citadel Advisors's EMBC Position: Q1 2026 in Review

Citadel Advisors increased its Embecta (EMBC) stake by 78% in Q1 2026, buying an estimated $1.78M and bringing the position to 391,819 shares worth $3.46M. The position accounts for ﹤0.01% of the portfolio, ranked #4981.

Citadel Advisors first reported a position in EMBC in Q3 2022 and has held it in 15 quarters since. The position peaked at $10.8M in Q4 2023. 339 funds tracked by Wall St. Rank hold EMBC as of Q1 2026.

  • Citadel Advisors held 391,819 shares of Embecta worth $3.46M as of Q1 2026.
  • Citadel Advisors bought 171,122 Embecta shares in Q1 2026, an estimated $1.78M.
  • Embecta made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4981 holding.
  • Citadel Advisors first reported a position in Embecta in Q3 2022 and has held it in 15 quarters since.
  • Citadel Advisors's Embecta position peaked at $10.8M in Q4 2023.
  • 339 funds tracked by Wall St. Rank held Embecta as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.